Skip to main content

Arnhold LLC

SEC CIK
0001733755
Latest filing
Jul 27, 2026

The latest 13F from Arnhold LLC covers Q2 2026 (filed Jul 27, 2026): 113 long positions worth $1.43B. The top 10 holdings make up 50.1% of the portfolio, and the largest is SPDR Gold Trust (GLD) at 10.1%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
4
Est. +$3.49M
Added
20
Est. +$51.0M
Reduced
31
Est. −$62.6M
Sold out
9
Est. −$24.6M

Top 5 holdings

Share of this quarter's portfolio value

  1. GLDSPDR Gold Trust
    10.1%$144.7MHistory
  2. IAUiShares Gold Trust
    9.3%$132.7MHistory
  3. COHRCoherent Corp.
    4.8%$68.6MHistory
  4. VRTVertiv Holdings Co
    4.8%$68.2MHistory
  5. GOOGLAlphabet Inc.
    4.7%$67.0MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. ADBEAdobe Inc.
    +$11.7MAddedHistory
  2. TAT&T Inc.
    +$11.2MAddedHistory
  3. BABAAlibaba Group Holding Ltd
    +$5.98MAddedHistory
  4. ADTADT Inc.
    +$4.63MAddedHistory
  5. BIOBio-Rad Laboratories, Inc.
    +$3.72MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. ADBEAdobe Inc.
    +0.58 pp1.2% → 1.8%History
  2. BIOBio-Rad Laboratories, Inc.
    +0.26 pp0.9% → 1.1%History
  3. EGEverest Group, Ltd.
    +0.26 pp1.1% → 1.4%History
  4. ADTADT Inc.
    +0.26 pp1.1% → 1.3%History
  5. ACNAccenture plc
    +0.17 pp0.0% → 0.2%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. COHRCoherent Corp.
    −$24.9MReducedHistory
  2. LITELumentum Holdings Inc.
    −$10.5MReducedHistory
  3. TERNTerns Pharmaceuticals, Inc.
    −$8.56MSold outHistory
  4. CWANClearwater Analytics Holdings, Inc.
    −$8.19MSold outHistory
  5. CSCOCisco Systems, Inc.
    −$6.98MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. TERNTerns Pharmaceuticals, Inc.
    −0.63 pp0.6% → 0.0%History
  2. CWANClearwater Analytics Holdings, Inc.
    −0.60 pp0.6% → 0.0%History
  3. DXCDXC Technology Co
    −0.33 pp0.6% → 0.2%History
  4. TXNTexas Instruments Inc
    −0.28 pp0.3% → 0.0%History
  5. DARDarling Ingredients Inc.
    −0.27 pp1.6% → 1.4%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.43B
+$67.5M (+5.0%) vs. prior quarter
Positions
113
−5 vs. prior quarter
Top 10 concentration
50.1%
Top 10 as share of value
Turnover
3.9%
Q2 2026, one quarter
Average holding period
17.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.43B (Q2 2026)

Q1 2021: $833.6MQ2 2021: $882.5MQ3 2021: $866.8MQ4 2021: $882.9MQ1 2022: $889.7MQ2 2022: $838.1MQ3 2022: $744.7MQ4 2022: $817.8MQ1 2023: $880.3MQ2 2023: $882.3MQ3 2023: $838.8MQ4 2023: $894.9MQ1 2024: $945.0MQ2 2024: $947.2MQ3 2024: $1.03BQ4 2024: $1.01BQ1 2025: $990.0MQ2 2025: $1.10BQ3 2025: $1.20BQ4 2025: $1.32BQ1 2026: $1.36BQ2 2026: $1.43B
Q1 2021Q2 2026
13F filings of Arnhold LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 27, 2026113$1.43BGLDIAUCOHRvs. Q1 2026SEC
Q1 2026May 11, 2026118$1.36BGLDIAULITEvs. Q4 2025SEC
Q4 2025Feb 9, 2026114$1.32BGLDIAUGOOGLvs. Q3 2025SEC
Q3 2025Nov 7, 2025116$1.20BGLDIAUGOOGLvs. Q2 2025SEC
Q2 2025Jul 29, 2025119$1.10BGLDIAUVRTvs. Q1 2025SEC
Q1 2025May 14, 2025115$990.0MGLDIAUTvs. Q4 2024SEC
Q4 2024Feb 14, 2025117$1.01BGLDIAUGOOGLvs. Q3 2024SEC
Q3 2024Nov 13, 2024111$1.03BGLDIAUGOOGLvs. Q2 2024SEC
Q2 2024Aug 1, 2024119$947.2MGLDIAUGOOGLvs. Q1 2024SEC
Q1 2024May 7, 2024120$945.0MGLDIAUGOOGLvs. Q4 2023SEC
Q4 2023Feb 5, 2024125$894.9MGLDIAUGOOGLvs. Q3 2023SEC
Q3 2023Oct 24, 2023124$838.8MGLDIAUGOOGLvs. Q2 2023SEC
Q2 2023Aug 8, 2023129$882.3MGLDIAUGOOGLvs. Q1 2023SEC
Q1 2023May 11, 2023125$880.3MGLDIAUGOOGLvs. Q4 2022SEC
Q4 2022Feb 7, 2023130$817.8MGLDIAUTvs. Q3 2022SEC
Q3 2022Oct 27, 2022133$744.7MGLDIAUTvs. Q2 2022SEC
Q2 2022Jul 26, 2022142$838.1MGLDIAUTvs. Q1 2022SEC
Q1 2022May 10, 2022136$889.7MGLDIAUTvs. Q4 2021SEC
Q4 2021Feb 8, 2022132$882.9MGLDIAUTvs. Q3 2021SEC
Q3 2021Oct 19, 2021135$866.8MGLDIAUTvs. Q2 2021SEC
Q2 2021Aug 4, 2021130$882.5MGLDIAUTvs. Q1 2021SEC
Q1 2021Apr 30, 2021134$833.6MGLDIAUABBV–SEC